What's Happening?
Allison and Stephen Ellsworth, the founders of the prebiotic soda company Poppi, have launched a new functional hydration beverage brand named Jetty. This launch, on November 9, 2026, comes approximately 18 months after PepsiCo acquired Poppi for $1.95
billion. Jetty offers bottled beverages and electrolyte powders in various flavors, targeting everyday consumers with a formulation that includes electrolytes, prebiotics, and vitamins. The brand emphasizes everyday hydration rather than athletic performance. This new venture follows an $8.9 million settlement in 2025 against Poppi, which resolved a consumer class action challenging the representations about its soda's gut health benefits. The lawsuit alleged that the amount of prebiotic fiber in Poppi was insufficient to provide the advertised benefits, though the settlement did not include an admission of wrongdoing. Jetty's marketing will need to carefully navigate health claims, as the Federal Trade Commission (FTC) requires appropriate evidence to support any implied or direct health benefits.
Why It's Important?
The launch of Jetty by the Poppi founders is significant for the U.S. beverage market, particularly in the functional drinks segment. It signals continued entrepreneurial activity and innovation within the industry, even from founders who have already achieved a major exit. The previous legal challenge faced by Poppi regarding its health claims underscores the increasing scrutiny on functional beverage marketing. This situation highlights the critical importance for new brands like Jetty to ensure that all health-related advertising is rigorously supported by scientific evidence, adhering to FTC and FDA standards. The focus on 'everyday hydration' with added prebiotics and vitamins positions Jetty to compete in a growing market for health-conscious consumers, but it also places a higher burden on the company to be transparent and accurate in its claims. This development could influence how other functional beverage companies approach product development, labeling, and marketing strategies to avoid similar legal issues.
What's Next?
Jetty is set to expand its retail presence significantly, aiming to reach approximately 3,200 stores by January 2027, with further expansion planned for March. The brand's success will depend on its ability to differentiate itself in a crowded hydration market and effectively communicate its benefits while adhering to strict regulatory guidelines for health claims. The founders' experience with Poppi, including the past litigation, will likely inform Jetty's approach to marketing and scientific substantiation. This could lead to a more cautious and evidence-based strategy for promoting the product's benefits. The FTC's Health Products Compliance Guidance will be a key framework for Jetty, requiring reliable evidence for any objective health claims. The beverage industry as a whole will be watching to see how Jetty navigates these challenges, potentially setting new precedents for how functional drinks are marketed and regulated in the U.S.
Beyond the Headlines
The re-entry of the Poppi founders into the functional beverage market with Jetty, particularly after the settlement concerning Poppi's health claims, raises deeper questions about consumer trust and corporate responsibility in the wellness industry. It highlights the ongoing tension between innovative product development and the need for scientific integrity in marketing. The incident with Poppi serves as a cautionary tale for the entire functional food and beverage sector, emphasizing that simply including a beneficial ingredient does not automatically translate to a proven health benefit in the final product. This situation could foster a more critical consumer base that demands greater transparency and verifiable evidence for health claims, pushing the industry towards more rigorous research and ethical advertising practices. Ultimately, this could lead to a more mature and trustworthy functional beverage market, where products are valued not just for their novelty but for their proven efficacy.
